SNAQ Launches AI-Powered Glucose Prediction feature

The new meal glucose prediction tool allows CGM users to anticipate their body’s reaction to food using a proprietary deep learning model and a unique digital twin approach. This innovation offers highly personalized insights for improved glucose control.

SNAQ also secured new funding led by the Diabetes Venture Fund at Serpentine Ventures, reinforcing investor confidence despite a tough market. CEO Aurelian Briner emphasized the company’s commitment to scaling innovations and transforming diabetes care. Looking ahead, SNAQ plans to introduce more AI-driven advancements to empower individuals in managing their health.

For more details, read the full press release or visit SNAQ’s website to learn more about their innovations in diabetes care.